Literature DB >> 22265392

The p53 network: cellular and systemic DNA damage responses in aging and cancer.

H Christian Reinhardt1, Björn Schumacher.   

Abstract

Genome instability contributes to cancer development and accelerates age-related pathologies as evidenced by a variety of congenital cancer susceptibility and progeroid syndromes that are caused by defects in genome maintenance mechanisms. DNA damage response (DDR) pathways that are mediated through the tumor suppressor p53 play an important role in the cell-intrinsic responses to genome instability, including a transient cell cycle arrest, senescence and apoptosis. Both senescence and apoptosis are powerful tumor-suppressive pathways preventing the uncontrolled proliferation of transformed cells. However, both pathways can potentially deplete stem and progenitor cell pools, thus promoting tissue degeneration and organ failure, which are both hallmarks of aging. p53 signaling is also involved in mediating non-cell-autonomous interactions with the innate immune system and in the systemic adjustments during the aging process. The network of p53 target genes thus functions as an important regulator of cancer prevention and aging. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265392      PMCID: PMC4120491          DOI: 10.1016/j.tig.2011.12.002

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  99 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Accumulation of senescent cells in mitotic tissue of aging primates.

Authors:  Jessie C Jeyapalan; Mark Ferreira; John M Sedivy; Utz Herbig
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

3.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Authors:  A Di Leonardo; S P Linke; K Clarkin; G M Wahl
Journal:  Genes Dev       Date:  1994-11-01       Impact factor: 11.361

4.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

5.  p53 status and the efficacy of cancer therapy in vivo.

Authors:  S W Lowe; S Bodis; A McClatchey; L Remington; H E Ruley; D E Fisher; D E Housman; T Jacks
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

6.  Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening.

Authors:  Anette Melk; Wipawee Kittikowit; Irwindeep Sandhu; Kieran M Halloran; Paul Grimm; Bernhard M W Schmidt; Philip F Halloran
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

7.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

8.  Delayed ageing through damage protection by the Arf/p53 pathway.

Authors:  Ander Matheu; Antonio Maraver; Peter Klatt; Ignacio Flores; Isabel Garcia-Cao; Consuelo Borras; Juana M Flores; Jose Viña; Maria A Blasco; Manuel Serrano
Journal:  Nature       Date:  2007-07-19       Impact factor: 49.962

Review 9.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

10.  Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome.

Authors:  Ingrid van der Pluijm; George A Garinis; Renata M C Brandt; Theo G M F Gorgels; Susan W Wijnhoven; Karin E M Diderich; Jan de Wit; James R Mitchell; Conny van Oostrom; Rudolf Beems; Laura J Niedernhofer; Susana Velasco; Errol C Friedberg; Kiyoji Tanaka; Harry van Steeg; Jan H J Hoeijmakers; Gijsbertus T J van der Horst
Journal:  PLoS Biol       Date:  2007-01       Impact factor: 8.029

View more
  183 in total

1.  The RASSF1A tumor suppressor regulates XPA-mediated DNA repair.

Authors:  Howard Donninger; Jennifer Clark; Francesca Rinaldo; Nicholas Nelson; Thibaut Barnoud; M Lee Schmidt; Katharine R Hobbing; Michele D Vos; Brian Sils; Geoffrey J Clark
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

3.  RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis.

Authors:  W Chen; Q Wang; L Bai; W Chen; X Wang; C S Tellez; S Leng; M T Padilla; T Nyunoya; S A Belinsky; Y Lin
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

4.  MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.

Authors:  D Jeong; J Kim; J Nam; H Sun; Y-H Lee; T-J Lee; R C T Aguiar; S-W Kim
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

5.  Mitochondrial matrix P53 sensitizes cells to oxidative stress.

Authors:  Christopher A Koczor; Rebecca A Torres; Earl J Fields; Amy Boyd; William Lewis
Journal:  Mitochondrion       Date:  2013-03-14       Impact factor: 4.160

6.  The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.

Authors:  W Du; S Amarachintha; A Wilson; Q Pang
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

7.  Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.

Authors:  Francesca Ponti; Serena Corsini; Maria Gnoli; Elena Pedrini; Marina Mordenti; Luca Sangiorgi
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

8.  Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Luo Wang; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2012-12-14       Impact factor: 4.944

9.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

10.  AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.

Authors:  Katja Höpker; Henning Hagmann; Safiya Khurshid; Shuhua Chen; Pia Hasskamp; Tamina Seeger-Nukpezah; Katharina Schilberg; Lukas Heukamp; Tobias Lamkemeyer; Martin L Sos; Roman K Thomas; Drew Lowery; Frederik Roels; Matthias Fischer; Max C Liebau; Ulrike Resch; Tülay Kisner; Fabian Röther; Malte P Bartram; Roman Ulrich Müller; Francesca Fabretti; Peter Kurschat; Björn Schumacher; Matthias Gaestel; René H Medema; Michael B Yaffe; Bernhard Schermer; H Christian Reinhardt; Thomas Benzing
Journal:  EMBO J       Date:  2012-08-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.